SlideShare a Scribd company logo
RENAL INVOLVEMENT IN
CHILDREN WITH COVID-19
MOJGAN MAZAHERI.MD
Pediatric nephrologist
Semnan university of medical science
KIDNEY DISEASE AMONG PATIENTS WITH COVID-19 CAN MANIFEST AS:
HEMATURIA,
PROTEINURIA,
FANCONI SYNDROME
ACUTE KIDNEY INJURY
AND PORTENDS A HIGHER RISK OF MORTALITY .
IT REMAINS UNCLEAR IF AKI IS LARGELY DUE TO HEMODYNAMIC CHANGES
AND CYTOKINE RELEASE OR IF THE VIRUS ALSO LEADS TO DIRECT
CYTOTOXICITY.
In a meta-analysis of approximately 13,000 mostly hospitalized patients,
the incidence of AKI was 17 percent, although the range of AKI
incidence in the included studies was broad (range 0.5 to 80 percent).
The reported incidence of AKI among patients with COVID-19, especially
those who are hospitalized, varies depending upon the severity of disease in
the patients who are studied.
In two large observational studies of over 5000 patients hospitalized with
COVID-19, AKI was noted among 32 to 37 percent of patients
Among patients with AKI, approximately one-half had mild disease (1.5- to 2-
fold increase in serum creatinine), and the remaining had moderate or severe
disease (more than doubling of creatinine).
FACTORS THAT MAY CONTRIBUTE TO COVID-19- ASSOCIATED ACUTE KIDNEY INJURY
Acute tubular injury
• Regional inflammation
• Direct viral infection
• Renal compartment syndrome
• Tissue hypoxia hypoperfusion leading to hypoxaemia,hypotension, hypovolaemia and
heart failure
• Nephrotoxic- induced injury (potentially associated with the use of antibiotics (vancomycin,
aminoglycosides, colistin) or antivirals (remdesivir, ritonavir))
• Rhabdomyolysis
Vascular injury
• Endotheliitis
• Microthrombi
• Thrombotic microangiopathy
Glomerular injury
• Collapsing glomerulopathy (potentially caused by interferon- associated podocyte injury)
• Glomerulonephritis
Interstitial injury
• Acute interstitial nephritis; infiltration by immune cells
• Interstitial oedema
MECHANISM OF RENAL INJURY
Direct effects on the renal tissues of infected patients
Deposition of immune complexes, such as viral antigens and antibodies or
virus-specific T-cell lymphocytes or antibodies in the kidney cells.
Infection-induced cytokines may have indirect effects on the renal tissue and
other organs due to hypoxia, hypoxemia, and shock.
Prerenal azotemia after gastrointestinal involvement usually as diarrhea and
vomiting can lead to AKI
Thrombotic microangiopathy is another cause leading AKI
multiple organ failure, caused by direct viral invasion or acute inflammatory
responses may cause AKI also.
Nephrotoxic drugs
.Potential pathophysiological mechanisms behind the development of COVID-19-
associated acute kidney injury.
it has been reported that angiotensin converting enzyme 2 (ACE2) is a
cell entry receptor for COVID-19 .
In this regard, Li et al. in a human study revealed that ACE2 expression
in the renal tissue was nearly 100 folds higher than in the lungs.
Accordingly, renal involvement may be caused by coronavirus through
an ACE2-dependent pathway.
• ACE2 receptors play a critical role in COVID-19 pathophysiology, due to the high
affinity of the SARS-CoV-2 protein S to membrane-bound ACE2
• Histologic studies have shown that ACE2 expression is about 100 times greater in the
kidneys compared to the lungs, the main pathway for viral infection. Therefore, it is
reasonable to predict that the kidney may be vulnerable to SARS-CoV-2 infection,
resulting in an injury caused by the direct cytopathic effect of the viral infection.
Ultrastructural in-situ hybridization used in some studies has confirmed presence of viral
RNA or viral proteins in kidney tissue.
• A renal post-mortem histopathological analysis of 26 adult patients with COVID-19
showed a prominent proximal acute tubular injury (ATI) associated with the loss of brush
border
SARS-COV-2 BINDING WITH ANGIOTENSIN-CONVERTING ENZYME (ACE) 2 AND INTERNALIZATION. FOR
CELLULAR ENTRY, SARS-COV-2 BINDS TO AND INTERNALIZES WITH ACE2 BY THE S1 SUBUNIT. MEMBRANE
FUSION IS MEDIATED VIA ACTIVATION OF SPIKES BY PROTEASES, AND VIRAL RNAS ARE RELEASED INTO THE
CYTOPLASM, FINISHING THE INFECTION WITH AND REPLICATION OF SARS-COV-2.
• COVID-19 virus can cause direct injury to podocytes and proximal
tubular cells through attaching to ACE2 receptors and cellular
transmembrane serine protease enzyme activity which may explain
proteinuria in COVID-19 patients.
• They also proposed that the simultaneous expression of ACE 2
receptor genes and cellular transmembrane serine protease in kidney
cells are not less than in other organs, therefore kidney is also a target
organ for the COVID-19
• ACE2 is highly expressed in the brush border of tubular cells and some coronavirus-like
particles were found in the renal proximal tubular epithelium supporting the cytopathic
mechanisms of kidney injury.
• As well as this cytopathic mechanism, a systemic condition is another potential mechanism
for kidney injury.
• Cytokine release syndrome (CRS) is being described in pediatric cases of COVID-19 and
might be a cofactor of renal manifestations.
• Hirano and Murakami described the potential role of ACE-AngII-AT1R axis dysregulation of
the RAS during the later phase of infection leading to downregulation of ACE2 that causes
CRS, characterized by high expression of IL-6 and TNF.
• Intrarenal inflammation,increased vascular permeability, volume depletion, and
cardiomyopathy,caused by these cytokines, might also lead to kidney failure.
• Other minor potential mechanisms of kidney injury are being identified, including systemic
effects of septic shock and the deposition of immune-complexes in the kidney.
• Vinturache et al. observed greater expression of the AT1R and the AT2R in kidneys and vasculature
in the course of fetal life than at any other time during the lifespan in response to cardiovascular and
renal demands.
• Ang II can bind to both receptors. As previously mentioned, the binding of Ang II to AT1R is
associated to pro-inflammatory activity and cytokine release. In turn, the binding of Ang II to AT2R
triggers vasodilatory effects, anti-inflammatory actions, and natriuresis.
• Hence, AT1R expression leads to inflammatory effects, while AT2R mediates protective effects. This
study has shown that the decline rate of expression of AT2R is greater than that of AT1R, causing a
predominance of AT1R over AT2R with aging.
• Therefore, children might present less severe cases of kidney injury associated with COVID-19 due
to this greater expression of AT2R than adults.
• However, further studies on ACE2 expression and other RAS molecules concentrations in children
are needed.
PEDIATR NEPHROL (2021) 36:163–169
BE AWARE OF ACUTE KIDNEY INJURY IN CRITICALLY ILL CHILDREN WITH COVID-19
postmortem renal histopathological analysis of 26 patients with
COVID-19, showed endothelial cell swelling and segmental fibrin
thrombi in glomerular capillary loops were consistent with the
histological features of TMA
SARS-COV-2 VIRUS DETECTION IN KIDNEY AND CHARACTERISTIC GLOMERULAR CHANGES. A SARS-COV-2
VIRUS DETECTION IN THE KIDNEY. FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SHOWS RNA EXPRESSION
OF SARS-COV-2 VIRUS (GREEN; ARROWS) AND ITS RECEPTOR ANGIOTENSIN-CONVERTING ENZYME 2
(ACE2; RED) IN THE GLOMERULUS OF THE KIDNEY OF A COVID-19 PATIENT. SCALE BAR = 20 ΜM B RENAL
HISTOLOGY OF A 38-YEAR-OLD PATIENT WITH COVID-19 AND ACUTE RENAL FAILURE. LEFT: MASSON–GOLDNER
STAINING SHOWS FRESH, WALL-BOUND FIBRIN THROMBI (ORANGE) IN THE GLOMERULAR
CAPILLARIES. RIGHT: IMMUNOHISTOCHEMISTRY FOR FIBRINOGEN/FIBRIN SHOWS WALL-ADHERENT
PRECIPITATES (RED) IN NUMEROUS GLOMERULAR CAPILLARIES
PEDIATR NEPHROL. 2021 JAN 26 : 1–5. PMCID: PMC7834948
ACUTE NECROTIZING GLOMERULONEPHRITIS ASSOCIATED WITH COVID-19 INFECTION: REPORT
OF TWO PEDIATRIC CASES
Basiratnia et al reported two cases of acute necrotizing
glomerulonephritis (GN) with fibrinoid necrosis in the context of
COVID-19 infection.
The one with more chronic features in the kidney biopsy progressed to
permanent kidney failure but the second one had an excellent
response to glucocorticoid pulse therapy with subsequent normal
kidney function at 2-month follow-up
• There is higher C-reactive protein (CRP) and lower thrombocyte count in the severe
form of disease
• This condition probably correlated with the advanced cytokine storm process that
involved in increasing proinflammatory mediators, such as interleukin-6 (IL-6),
transforming growth factor-β (TGF-β), Tumor necroting factor-α (TNF-α), vascular
endothel growth factor (VEGF), platelet derived growth factor (PDGF), IL-10, and soluble
urokinase plasminogen activator receptor (suPAR).
• Those proinflammatory and anti-inflammatory mediators released led to a disturbance
in clotting cascades, while thrombus occurred in the later stages, and plasminogen
stimulation with antithrombin-III activation took place in the fibrinolytic system
• Therefore, fibrinolytic and fibrinogen substances were depleted, while clot formation and
bleeding associated with disseminated intravascular coagulation (DIC) also occurred at
the same time
2020 UPDATE ON THE RENIN–ANGIOTENSIN–ALDOSTERONE SYSTEM
IN PEDIATRIC KIDNEY DISEASE AND ITS INTERACTIONS WITH CORONAVIRUS
PEDIATRIC NEPHROLOGY
HTTPS://DOI.ORG/10.1007/S00467-020-04759-1
• A range of immune-related cascades might be activated by the exacerbation of
ACE/Ang II/AT1R, including the synthesis and release of pro-inflammatory
cytokines, including IL-1,IL-6, and TNF-α
• This process, added to viral intrinsic activation of both innate and adaptive immune
systems, may explain the higher levels of IL-6, IL-2R, IL-10, and TNF-α, as well as
lower CD4+ and CD8+ levels in COVID-19 patients
• Pediatric patients, in particular presented increased serum creatine kinase MB,
procalcitonin and C reactive protein, lymphocytopenia, and leukopenia associated
with higher disease severity
• A meta-analysis including pediatric patients with SARS-CoV- infection conducted by Zhang et al.
demonstrated that 5% (22/139) had increased urea and 4% (48/184) had increased creatinine.
• A large number of patients had no symptom on admission
• A cohort study by Stewart et al. showed a frequency of increased serum creatinine in 46% (n =
24), and 29% (n = 15) of hospitalised patients that meet the diagnosis criteria for acute kidney
injury.
• Out of these 15 inpatients with AKI, 93% (n = 14) were admitted to the pediatric intensive care unit
(PICU) and 73% (n = 11) were associated with with multisystem inflammatory syndrome in children
(MIS-C) temporarily associated with SARS-CoV-2.
• AKI may be the main cause of critical illness in pediatric patients, requiring PICU admission.
• Patients with AKI are recommended to receive CRRT in order to both protect renal function and
remove inflammatory cytokines, which may accelerate the process of disease recovery.
ACUTE KIDNEY INJURY IN CHILDREN WITH COVID-19
KING ABDULAZIZ UNIVERSITY ,RESEARCH SQUARE
▪ in the setting of COVID-19, AKI occurred in approximately one-fifth of our
hospitalized children, and more than one-third of those required PICU admission.
▪ AKI is more commonly found in younger children and in those with comorbid
conditions.
• AKI is associated with increased mortality and morbidity.
• A small proportion of children with AKI can develop residual renal impairment at the
time of discharge.
• Nonetheless, it tends to be milder than in adults, with a lower incidence of oliguria
and less need for RRT.
CRIT.CARE.MED 2020 DEC;48(12):1809-1818.
ACUTE KIDNEY INJURY IN PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY
ASSOCIATED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 PANDEMIC:
EXPERIENCE FROM PICUS ACROSS UNITED KINGDOM
.
• Severe acute kidney injury occurred in just over a quarter of children
admitted to United Kingdom PICUs with pediatric inflammatory multisystem
syndrome temporally associated with severe acute respiratory syndrome
coronavirus-2.
• Hyperferritinemia was significantly associated with severe acute kidney
injury.
• Severe acute kidney injury was associated with increased duration of stay
and ventilation.
• Although short-term outcomes for acute kidney injury in pediatric
inflammatory multisystem syndrome temporally associated with severe
acute respiratory syndrome coronavirus-2 appear good, long-term outcomes
are unknown.
ARCH PEDIATR INFECT DIS. 2021 JANUARY; 9(1):E106597.
RENAL INVOLVEMENT IN COVID-19 AMONG IRANIAN CHILDREN
• In total of 71 patients , 10% of the patients had oliguria, 7.7% had edema, and 3% had
hypertension. No patients showed signs of hypotension. The first urinalysis showed
proteinuria,leukocyturia, and hematuria in 46%, 24%, and 23% of the patients, respectively.
Overall, 40.7% of the patients showed some degree of renal involvement.
• During hospitalization the peak serum creatinine level was 9.6 mg/dL(range: 0.4 - 9.6 mg/dL;
mean: 1.31 mg/dL), and the prevalence of AKI was 34.5%.
• Based on the pRIFLE classification stage I (risk group) was found in 20% of the patients,
stageII (injury group) in 25% of the patients, and stage III (failure group) in 55% of the patients
with AKI.
• Compared to patients with normal renal function those with elevated serum creatinine levels
on admission were predominantly older and more severely ill.
• The total mortality rate of the patients was 12.67%. The rate of inhospital death among
patients with AKI was estimated at 30%.
• Independent predictors of AKI included;
• being older
• Black American
• male
• obesity
• diabetes
• hypertension
• cardiovascular disease
• low baseline estimated glomerular filtration rate (eGFR)
• higher interleukin-6 level
• requiring mechanical ventilation
• vasopressor medications
•
Key points
•
• Over a quarter of patients hospitalized with coronavirus disease 2019 (COVID-19)
•
have been reported to develop acute kidney injury (AKI).
•
• Low molecular weight proteinuria, Fanconi syndrome and histological findings point
•
towards tubular injury.
•
• Analyses of kidney biopsy samples from patients with COVID-19 and AKI have
•
inconsistently reported viral infection of kidney cells.
•
• Collapsing glomerulopathy has been identified in patients with high- risk APOL1
•
genotypes, mostly in those without severe respiratory symptoms.
•
• Regional inflammation, endothelial injury and renal microthrombi have been
reported
•
• Anti- inflammatory drugs (for example, steroids and IL-6 receptor blockers) seem to
•
limit the development of severe AKI in patients with COVID-19.
renal involvement in children with covid19

More Related Content

What's hot

Phenotypes and Coagulopathy in covid19
Phenotypes and Coagulopathy in covid19Phenotypes and Coagulopathy in covid19
Phenotypes and Coagulopathy in covid19
Athanassios Antonopoulos MD, PhD
 
Vaccination in CKD Patients
Vaccination in CKD PatientsVaccination in CKD Patients
Vaccination in CKD Patients
drsanjaymaitra
 
NOAC in covid-19
NOAC in covid-19NOAC in covid-19
NOAC in covid-19
Dr.Pankaj Jariwala
 
Hiv associated nephropathy(Dr. sood)
Hiv associated nephropathy(Dr. sood)Hiv associated nephropathy(Dr. sood)
Hiv associated nephropathy(Dr. sood)
polobismuth
 
AKI in COVID 19 infection.
AKI in COVID 19 infection.AKI in COVID 19 infection.
AKI in COVID 19 infection.
Dr. Manoj Deepak
 
Anti gbm disease
Anti gbm diseaseAnti gbm disease
Anti gbm disease
Ajay Kurian
 
Another Day, Another Fever
Another Day, Another FeverAnother Day, Another Fever
Another Day, Another Fever
UC San Diego AntiViral Research Center
 
Dx y tx de sepsis 2020
Dx y tx de sepsis 2020Dx y tx de sepsis 2020
Dx y tx de sepsis 2020
RaulPerez387300
 
Haemophagocytic Syndrome
Haemophagocytic SyndromeHaemophagocytic Syndrome
Haemophagocytic Syndrome軒名 林
 
Hl hing
Hl hingHl hing
Hl hing
tyfngnc
 
Hidrocortisona en shock vasodilatado
Hidrocortisona en shock vasodilatadoHidrocortisona en shock vasodilatado
Hidrocortisona en shock vasodilatado
RaulPerez387300
 
Shock septico 2020
Shock septico 2020Shock septico 2020
Shock septico 2020
RaulPerez387300
 
Early diagnosis of graft rejection in renal transplantation
Early diagnosis of graft rejection in renal transplantationEarly diagnosis of graft rejection in renal transplantation
Early diagnosis of graft rejection in renal transplantationALAA AWN
 
Hivan
HivanHivan
International Journal of Neurological Disorders
International Journal of Neurological DisordersInternational Journal of Neurological Disorders
International Journal of Neurological Disorders
SciRes Literature LLC. | Open Access Journals
 
Eosinophilic granulomatosis with polyangitis
Eosinophilic granulomatosis with polyangitisEosinophilic granulomatosis with polyangitis
Eosinophilic granulomatosis with polyangitis
Marwa Besar
 
Covid and heart
Covid and heartCovid and heart
Covid and heart
এ হক
 

What's hot (20)

Phenotypes and Coagulopathy in covid19
Phenotypes and Coagulopathy in covid19Phenotypes and Coagulopathy in covid19
Phenotypes and Coagulopathy in covid19
 
Mas
MasMas
Mas
 
Vaccination in CKD Patients
Vaccination in CKD PatientsVaccination in CKD Patients
Vaccination in CKD Patients
 
NOAC in covid-19
NOAC in covid-19NOAC in covid-19
NOAC in covid-19
 
Hiv associated nephropathy(Dr. sood)
Hiv associated nephropathy(Dr. sood)Hiv associated nephropathy(Dr. sood)
Hiv associated nephropathy(Dr. sood)
 
AKI in COVID 19 infection.
AKI in COVID 19 infection.AKI in COVID 19 infection.
AKI in COVID 19 infection.
 
Anti gbm disease
Anti gbm diseaseAnti gbm disease
Anti gbm disease
 
Another Day, Another Fever
Another Day, Another FeverAnother Day, Another Fever
Another Day, Another Fever
 
Dx y tx de sepsis 2020
Dx y tx de sepsis 2020Dx y tx de sepsis 2020
Dx y tx de sepsis 2020
 
Haemophagocytic Syndrome
Haemophagocytic SyndromeHaemophagocytic Syndrome
Haemophagocytic Syndrome
 
Hl hing
Hl hingHl hing
Hl hing
 
Hidrocortisona en shock vasodilatado
Hidrocortisona en shock vasodilatadoHidrocortisona en shock vasodilatado
Hidrocortisona en shock vasodilatado
 
Shock septico 2020
Shock septico 2020Shock septico 2020
Shock septico 2020
 
Early diagnosis of graft rejection in renal transplantation
Early diagnosis of graft rejection in renal transplantationEarly diagnosis of graft rejection in renal transplantation
Early diagnosis of graft rejection in renal transplantation
 
SIRS
SIRSSIRS
SIRS
 
Hivan
HivanHivan
Hivan
 
International Journal of Neurological Disorders
International Journal of Neurological DisordersInternational Journal of Neurological Disorders
International Journal of Neurological Disorders
 
Eosinophilic granulomatosis with polyangitis
Eosinophilic granulomatosis with polyangitisEosinophilic granulomatosis with polyangitis
Eosinophilic granulomatosis with polyangitis
 
Sirs Mods
Sirs ModsSirs Mods
Sirs Mods
 
Covid and heart
Covid and heartCovid and heart
Covid and heart
 

Similar to renal involvement in children with covid19

SLIDE WEBINAR COV-19.pptx
SLIDE WEBINAR COV-19.pptxSLIDE WEBINAR COV-19.pptx
SLIDE WEBINAR COV-19.pptx
dana730605
 
Covid 19
Covid 19Covid 19
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
Book spike sars-cov-2  as procoagulant factor and vaccine class effect hypoth...Book spike sars-cov-2  as procoagulant factor and vaccine class effect hypoth...
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
M. Luisetto Pharm.D.Spec. Pharmacology
 
COVID-19; Updates on Pathophysiology and Laboratory Investigations
COVID-19; Updates on Pathophysiology and Laboratory InvestigationsCOVID-19; Updates on Pathophysiology and Laboratory Investigations
COVID-19; Updates on Pathophysiology and Laboratory Investigations
Abdulsalam Al-Ani
 
The science underlying covid 19
The science underlying covid 19The science underlying covid 19
The science underlying covid 19
Ramachandra Barik
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
semualkaira
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
semualkaira
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
semualkaira
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
semualkaira
 
antifibrotic drugs
antifibrotic drugsantifibrotic drugs
antifibrotic drugs
DrVeereshDhanni
 
Transverse Myelitis in a Patient with COVID-19: A Case Report
Transverse Myelitis in a Patient with COVID-19: A Case ReportTransverse Myelitis in a Patient with COVID-19: A Case Report
Transverse Myelitis in a Patient with COVID-19: A Case Report
komalicarol
 
Overview-on-Liver-Damage.9092648.powerpoint.pptx
Overview-on-Liver-Damage.9092648.powerpoint.pptxOverview-on-Liver-Damage.9092648.powerpoint.pptx
Overview-on-Liver-Damage.9092648.powerpoint.pptx
RioPutraPamungkas
 
Covid infection and kidney
Covid infection and  kidneyCovid infection and  kidney
Covid infection and kidney
Moustafa Rezk
 
Covid 19 in children
Covid 19 in childrenCovid 19 in children
Covid 19 in children
Dr M Sanjeevappa
 
Covid 19
Covid 19Covid 19
Covid 19
Utkarsh Sharma
 
Biochemical biomarkers alterations in coronavirus disease 2019
Biochemical biomarkers alterations in coronavirus disease 2019Biochemical biomarkers alterations in coronavirus disease 2019
Biochemical biomarkers alterations in coronavirus disease 2019
sp medical coolege
 
Controversies in the management of COVID-19
Controversies  in the management of COVID-19Controversies  in the management of COVID-19
Controversies in the management of COVID-19
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
COVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspectiveCOVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspective
Valentina Corona
 
Sarcoidosis and IgG4
Sarcoidosis and IgG4Sarcoidosis and IgG4
Sarcoidosis and IgG4
ikramdr01
 

Similar to renal involvement in children with covid19 (20)

SLIDE WEBINAR COV-19.pptx
SLIDE WEBINAR COV-19.pptxSLIDE WEBINAR COV-19.pptx
SLIDE WEBINAR COV-19.pptx
 
Covid 19
Covid 19Covid 19
Covid 19
 
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
Book spike sars-cov-2  as procoagulant factor and vaccine class effect hypoth...Book spike sars-cov-2  as procoagulant factor and vaccine class effect hypoth...
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
 
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
Spike sars cov-2 protein as procoagulant factor and vaccine class effect hypo...
 
COVID-19; Updates on Pathophysiology and Laboratory Investigations
COVID-19; Updates on Pathophysiology and Laboratory InvestigationsCOVID-19; Updates on Pathophysiology and Laboratory Investigations
COVID-19; Updates on Pathophysiology and Laboratory Investigations
 
The science underlying covid 19
The science underlying covid 19The science underlying covid 19
The science underlying covid 19
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
 
Covid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism PerspectiveCovid-19 and Liver Injury: Mechanism Perspective
Covid-19 and Liver Injury: Mechanism Perspective
 
antifibrotic drugs
antifibrotic drugsantifibrotic drugs
antifibrotic drugs
 
Transverse Myelitis in a Patient with COVID-19: A Case Report
Transverse Myelitis in a Patient with COVID-19: A Case ReportTransverse Myelitis in a Patient with COVID-19: A Case Report
Transverse Myelitis in a Patient with COVID-19: A Case Report
 
Overview-on-Liver-Damage.9092648.powerpoint.pptx
Overview-on-Liver-Damage.9092648.powerpoint.pptxOverview-on-Liver-Damage.9092648.powerpoint.pptx
Overview-on-Liver-Damage.9092648.powerpoint.pptx
 
Covid infection and kidney
Covid infection and  kidneyCovid infection and  kidney
Covid infection and kidney
 
Covid 19 in children
Covid 19 in childrenCovid 19 in children
Covid 19 in children
 
Covid 19
Covid 19Covid 19
Covid 19
 
Biochemical biomarkers alterations in coronavirus disease 2019
Biochemical biomarkers alterations in coronavirus disease 2019Biochemical biomarkers alterations in coronavirus disease 2019
Biochemical biomarkers alterations in coronavirus disease 2019
 
Controversies in the management of COVID-19
Controversies  in the management of COVID-19Controversies  in the management of COVID-19
Controversies in the management of COVID-19
 
COVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspectiveCOVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspective
 
Sarcoidosis and IgG4
Sarcoidosis and IgG4Sarcoidosis and IgG4
Sarcoidosis and IgG4
 

More from Pediatric Nephrology

Antirejection medication
Antirejection medication Antirejection medication
Antirejection medication
Pediatric Nephrology
 
kidney transplantation in children
kidney transplantation in childrenkidney transplantation in children
kidney transplantation in children
Pediatric Nephrology
 
hyponatremia
hyponatremiahyponatremia
hyponatremia
Pediatric Nephrology
 
hypernatremia management
hypernatremia managementhypernatremia management
hypernatremia management
Pediatric Nephrology
 
K balance
K balance K balance
Growth and nutrition in CKD child
Growth and nutrition in CKD childGrowth and nutrition in CKD child
Growth and nutrition in CKD child
Pediatric Nephrology
 
Renal osteodystrophy
Renal osteodystrophyRenal osteodystrophy
Renal osteodystrophy
Pediatric Nephrology
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKD
Pediatric Nephrology
 
probiotics in kidney disease
probiotics  in kidney diseaseprobiotics  in kidney disease
probiotics in kidney disease
Pediatric Nephrology
 
complication of peritoneal dialysis
complication of peritoneal dialysiscomplication of peritoneal dialysis
complication of peritoneal dialysis
Pediatric Nephrology
 
peritoneal dialysis in children
peritoneal dialysis in childrenperitoneal dialysis in children
peritoneal dialysis in children
Pediatric Nephrology
 
immunization in renal disease
immunization in renal diseaseimmunization in renal disease
immunization in renal disease
Pediatric Nephrology
 
kidney and the eye
kidney and the eyekidney and the eye
kidney and the eye
Pediatric Nephrology
 
Prevention of urine stone
Prevention of  urine stonePrevention of  urine stone
Prevention of urine stone
Pediatric Nephrology
 
treament of renal stone with children
treament of  renal stone with childrentreament of  renal stone with children
treament of renal stone with children
Pediatric Nephrology
 
risk factors of urolithiasis in children
risk factors of urolithiasis in childrenrisk factors of urolithiasis in children
risk factors of urolithiasis in children
Pediatric Nephrology
 
clinical approach to renal stone in pedaitrics
clinical approach to renal stone in pedaitricsclinical approach to renal stone in pedaitrics
clinical approach to renal stone in pedaitrics
Pediatric Nephrology
 
Hematuria
HematuriaHematuria
clinical approach to pediatric proteinuria
clinical approach to pediatric proteinuria clinical approach to pediatric proteinuria
clinical approach to pediatric proteinuria
Pediatric Nephrology
 
management of hypertension in neonates and infants
management of hypertension in neonates and infantsmanagement of hypertension in neonates and infants
management of hypertension in neonates and infants
Pediatric Nephrology
 

More from Pediatric Nephrology (20)

Antirejection medication
Antirejection medication Antirejection medication
Antirejection medication
 
kidney transplantation in children
kidney transplantation in childrenkidney transplantation in children
kidney transplantation in children
 
hyponatremia
hyponatremiahyponatremia
hyponatremia
 
hypernatremia management
hypernatremia managementhypernatremia management
hypernatremia management
 
K balance
K balance K balance
K balance
 
Growth and nutrition in CKD child
Growth and nutrition in CKD childGrowth and nutrition in CKD child
Growth and nutrition in CKD child
 
Renal osteodystrophy
Renal osteodystrophyRenal osteodystrophy
Renal osteodystrophy
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKD
 
probiotics in kidney disease
probiotics  in kidney diseaseprobiotics  in kidney disease
probiotics in kidney disease
 
complication of peritoneal dialysis
complication of peritoneal dialysiscomplication of peritoneal dialysis
complication of peritoneal dialysis
 
peritoneal dialysis in children
peritoneal dialysis in childrenperitoneal dialysis in children
peritoneal dialysis in children
 
immunization in renal disease
immunization in renal diseaseimmunization in renal disease
immunization in renal disease
 
kidney and the eye
kidney and the eyekidney and the eye
kidney and the eye
 
Prevention of urine stone
Prevention of  urine stonePrevention of  urine stone
Prevention of urine stone
 
treament of renal stone with children
treament of  renal stone with childrentreament of  renal stone with children
treament of renal stone with children
 
risk factors of urolithiasis in children
risk factors of urolithiasis in childrenrisk factors of urolithiasis in children
risk factors of urolithiasis in children
 
clinical approach to renal stone in pedaitrics
clinical approach to renal stone in pedaitricsclinical approach to renal stone in pedaitrics
clinical approach to renal stone in pedaitrics
 
Hematuria
HematuriaHematuria
Hematuria
 
clinical approach to pediatric proteinuria
clinical approach to pediatric proteinuria clinical approach to pediatric proteinuria
clinical approach to pediatric proteinuria
 
management of hypertension in neonates and infants
management of hypertension in neonates and infantsmanagement of hypertension in neonates and infants
management of hypertension in neonates and infants
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 

renal involvement in children with covid19

  • 1. RENAL INVOLVEMENT IN CHILDREN WITH COVID-19 MOJGAN MAZAHERI.MD Pediatric nephrologist Semnan university of medical science
  • 2. KIDNEY DISEASE AMONG PATIENTS WITH COVID-19 CAN MANIFEST AS: HEMATURIA, PROTEINURIA, FANCONI SYNDROME ACUTE KIDNEY INJURY AND PORTENDS A HIGHER RISK OF MORTALITY . IT REMAINS UNCLEAR IF AKI IS LARGELY DUE TO HEMODYNAMIC CHANGES AND CYTOKINE RELEASE OR IF THE VIRUS ALSO LEADS TO DIRECT CYTOTOXICITY.
  • 3. In a meta-analysis of approximately 13,000 mostly hospitalized patients, the incidence of AKI was 17 percent, although the range of AKI incidence in the included studies was broad (range 0.5 to 80 percent).
  • 4. The reported incidence of AKI among patients with COVID-19, especially those who are hospitalized, varies depending upon the severity of disease in the patients who are studied. In two large observational studies of over 5000 patients hospitalized with COVID-19, AKI was noted among 32 to 37 percent of patients Among patients with AKI, approximately one-half had mild disease (1.5- to 2- fold increase in serum creatinine), and the remaining had moderate or severe disease (more than doubling of creatinine).
  • 5. FACTORS THAT MAY CONTRIBUTE TO COVID-19- ASSOCIATED ACUTE KIDNEY INJURY Acute tubular injury • Regional inflammation • Direct viral infection • Renal compartment syndrome • Tissue hypoxia hypoperfusion leading to hypoxaemia,hypotension, hypovolaemia and heart failure • Nephrotoxic- induced injury (potentially associated with the use of antibiotics (vancomycin, aminoglycosides, colistin) or antivirals (remdesivir, ritonavir)) • Rhabdomyolysis Vascular injury • Endotheliitis • Microthrombi • Thrombotic microangiopathy Glomerular injury • Collapsing glomerulopathy (potentially caused by interferon- associated podocyte injury) • Glomerulonephritis Interstitial injury • Acute interstitial nephritis; infiltration by immune cells • Interstitial oedema
  • 6. MECHANISM OF RENAL INJURY Direct effects on the renal tissues of infected patients Deposition of immune complexes, such as viral antigens and antibodies or virus-specific T-cell lymphocytes or antibodies in the kidney cells. Infection-induced cytokines may have indirect effects on the renal tissue and other organs due to hypoxia, hypoxemia, and shock. Prerenal azotemia after gastrointestinal involvement usually as diarrhea and vomiting can lead to AKI Thrombotic microangiopathy is another cause leading AKI multiple organ failure, caused by direct viral invasion or acute inflammatory responses may cause AKI also. Nephrotoxic drugs
  • 7. .Potential pathophysiological mechanisms behind the development of COVID-19- associated acute kidney injury.
  • 8. it has been reported that angiotensin converting enzyme 2 (ACE2) is a cell entry receptor for COVID-19 . In this regard, Li et al. in a human study revealed that ACE2 expression in the renal tissue was nearly 100 folds higher than in the lungs. Accordingly, renal involvement may be caused by coronavirus through an ACE2-dependent pathway.
  • 9. • ACE2 receptors play a critical role in COVID-19 pathophysiology, due to the high affinity of the SARS-CoV-2 protein S to membrane-bound ACE2 • Histologic studies have shown that ACE2 expression is about 100 times greater in the kidneys compared to the lungs, the main pathway for viral infection. Therefore, it is reasonable to predict that the kidney may be vulnerable to SARS-CoV-2 infection, resulting in an injury caused by the direct cytopathic effect of the viral infection. Ultrastructural in-situ hybridization used in some studies has confirmed presence of viral RNA or viral proteins in kidney tissue. • A renal post-mortem histopathological analysis of 26 adult patients with COVID-19 showed a prominent proximal acute tubular injury (ATI) associated with the loss of brush border
  • 10. SARS-COV-2 BINDING WITH ANGIOTENSIN-CONVERTING ENZYME (ACE) 2 AND INTERNALIZATION. FOR CELLULAR ENTRY, SARS-COV-2 BINDS TO AND INTERNALIZES WITH ACE2 BY THE S1 SUBUNIT. MEMBRANE FUSION IS MEDIATED VIA ACTIVATION OF SPIKES BY PROTEASES, AND VIRAL RNAS ARE RELEASED INTO THE CYTOPLASM, FINISHING THE INFECTION WITH AND REPLICATION OF SARS-COV-2.
  • 11. • COVID-19 virus can cause direct injury to podocytes and proximal tubular cells through attaching to ACE2 receptors and cellular transmembrane serine protease enzyme activity which may explain proteinuria in COVID-19 patients. • They also proposed that the simultaneous expression of ACE 2 receptor genes and cellular transmembrane serine protease in kidney cells are not less than in other organs, therefore kidney is also a target organ for the COVID-19
  • 12.
  • 13. • ACE2 is highly expressed in the brush border of tubular cells and some coronavirus-like particles were found in the renal proximal tubular epithelium supporting the cytopathic mechanisms of kidney injury. • As well as this cytopathic mechanism, a systemic condition is another potential mechanism for kidney injury. • Cytokine release syndrome (CRS) is being described in pediatric cases of COVID-19 and might be a cofactor of renal manifestations. • Hirano and Murakami described the potential role of ACE-AngII-AT1R axis dysregulation of the RAS during the later phase of infection leading to downregulation of ACE2 that causes CRS, characterized by high expression of IL-6 and TNF. • Intrarenal inflammation,increased vascular permeability, volume depletion, and cardiomyopathy,caused by these cytokines, might also lead to kidney failure. • Other minor potential mechanisms of kidney injury are being identified, including systemic effects of septic shock and the deposition of immune-complexes in the kidney.
  • 14.
  • 15. • Vinturache et al. observed greater expression of the AT1R and the AT2R in kidneys and vasculature in the course of fetal life than at any other time during the lifespan in response to cardiovascular and renal demands. • Ang II can bind to both receptors. As previously mentioned, the binding of Ang II to AT1R is associated to pro-inflammatory activity and cytokine release. In turn, the binding of Ang II to AT2R triggers vasodilatory effects, anti-inflammatory actions, and natriuresis. • Hence, AT1R expression leads to inflammatory effects, while AT2R mediates protective effects. This study has shown that the decline rate of expression of AT2R is greater than that of AT1R, causing a predominance of AT1R over AT2R with aging. • Therefore, children might present less severe cases of kidney injury associated with COVID-19 due to this greater expression of AT2R than adults. • However, further studies on ACE2 expression and other RAS molecules concentrations in children are needed.
  • 16.
  • 17. PEDIATR NEPHROL (2021) 36:163–169 BE AWARE OF ACUTE KIDNEY INJURY IN CRITICALLY ILL CHILDREN WITH COVID-19 postmortem renal histopathological analysis of 26 patients with COVID-19, showed endothelial cell swelling and segmental fibrin thrombi in glomerular capillary loops were consistent with the histological features of TMA
  • 18. SARS-COV-2 VIRUS DETECTION IN KIDNEY AND CHARACTERISTIC GLOMERULAR CHANGES. A SARS-COV-2 VIRUS DETECTION IN THE KIDNEY. FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SHOWS RNA EXPRESSION OF SARS-COV-2 VIRUS (GREEN; ARROWS) AND ITS RECEPTOR ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2; RED) IN THE GLOMERULUS OF THE KIDNEY OF A COVID-19 PATIENT. SCALE BAR = 20 ΜM B RENAL HISTOLOGY OF A 38-YEAR-OLD PATIENT WITH COVID-19 AND ACUTE RENAL FAILURE. LEFT: MASSON–GOLDNER STAINING SHOWS FRESH, WALL-BOUND FIBRIN THROMBI (ORANGE) IN THE GLOMERULAR CAPILLARIES. RIGHT: IMMUNOHISTOCHEMISTRY FOR FIBRINOGEN/FIBRIN SHOWS WALL-ADHERENT PRECIPITATES (RED) IN NUMEROUS GLOMERULAR CAPILLARIES
  • 19. PEDIATR NEPHROL. 2021 JAN 26 : 1–5. PMCID: PMC7834948 ACUTE NECROTIZING GLOMERULONEPHRITIS ASSOCIATED WITH COVID-19 INFECTION: REPORT OF TWO PEDIATRIC CASES Basiratnia et al reported two cases of acute necrotizing glomerulonephritis (GN) with fibrinoid necrosis in the context of COVID-19 infection. The one with more chronic features in the kidney biopsy progressed to permanent kidney failure but the second one had an excellent response to glucocorticoid pulse therapy with subsequent normal kidney function at 2-month follow-up
  • 20. • There is higher C-reactive protein (CRP) and lower thrombocyte count in the severe form of disease • This condition probably correlated with the advanced cytokine storm process that involved in increasing proinflammatory mediators, such as interleukin-6 (IL-6), transforming growth factor-β (TGF-β), Tumor necroting factor-α (TNF-α), vascular endothel growth factor (VEGF), platelet derived growth factor (PDGF), IL-10, and soluble urokinase plasminogen activator receptor (suPAR). • Those proinflammatory and anti-inflammatory mediators released led to a disturbance in clotting cascades, while thrombus occurred in the later stages, and plasminogen stimulation with antithrombin-III activation took place in the fibrinolytic system • Therefore, fibrinolytic and fibrinogen substances were depleted, while clot formation and bleeding associated with disseminated intravascular coagulation (DIC) also occurred at the same time
  • 21. 2020 UPDATE ON THE RENIN–ANGIOTENSIN–ALDOSTERONE SYSTEM IN PEDIATRIC KIDNEY DISEASE AND ITS INTERACTIONS WITH CORONAVIRUS PEDIATRIC NEPHROLOGY HTTPS://DOI.ORG/10.1007/S00467-020-04759-1 • A range of immune-related cascades might be activated by the exacerbation of ACE/Ang II/AT1R, including the synthesis and release of pro-inflammatory cytokines, including IL-1,IL-6, and TNF-α • This process, added to viral intrinsic activation of both innate and adaptive immune systems, may explain the higher levels of IL-6, IL-2R, IL-10, and TNF-α, as well as lower CD4+ and CD8+ levels in COVID-19 patients • Pediatric patients, in particular presented increased serum creatine kinase MB, procalcitonin and C reactive protein, lymphocytopenia, and leukopenia associated with higher disease severity
  • 22. • A meta-analysis including pediatric patients with SARS-CoV- infection conducted by Zhang et al. demonstrated that 5% (22/139) had increased urea and 4% (48/184) had increased creatinine. • A large number of patients had no symptom on admission • A cohort study by Stewart et al. showed a frequency of increased serum creatinine in 46% (n = 24), and 29% (n = 15) of hospitalised patients that meet the diagnosis criteria for acute kidney injury. • Out of these 15 inpatients with AKI, 93% (n = 14) were admitted to the pediatric intensive care unit (PICU) and 73% (n = 11) were associated with with multisystem inflammatory syndrome in children (MIS-C) temporarily associated with SARS-CoV-2. • AKI may be the main cause of critical illness in pediatric patients, requiring PICU admission. • Patients with AKI are recommended to receive CRRT in order to both protect renal function and remove inflammatory cytokines, which may accelerate the process of disease recovery.
  • 23. ACUTE KIDNEY INJURY IN CHILDREN WITH COVID-19 KING ABDULAZIZ UNIVERSITY ,RESEARCH SQUARE ▪ in the setting of COVID-19, AKI occurred in approximately one-fifth of our hospitalized children, and more than one-third of those required PICU admission. ▪ AKI is more commonly found in younger children and in those with comorbid conditions. • AKI is associated with increased mortality and morbidity. • A small proportion of children with AKI can develop residual renal impairment at the time of discharge. • Nonetheless, it tends to be milder than in adults, with a lower incidence of oliguria and less need for RRT.
  • 24. CRIT.CARE.MED 2020 DEC;48(12):1809-1818. ACUTE KIDNEY INJURY IN PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 PANDEMIC: EXPERIENCE FROM PICUS ACROSS UNITED KINGDOM . • Severe acute kidney injury occurred in just over a quarter of children admitted to United Kingdom PICUs with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2. • Hyperferritinemia was significantly associated with severe acute kidney injury. • Severe acute kidney injury was associated with increased duration of stay and ventilation. • Although short-term outcomes for acute kidney injury in pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 appear good, long-term outcomes are unknown.
  • 25. ARCH PEDIATR INFECT DIS. 2021 JANUARY; 9(1):E106597. RENAL INVOLVEMENT IN COVID-19 AMONG IRANIAN CHILDREN • In total of 71 patients , 10% of the patients had oliguria, 7.7% had edema, and 3% had hypertension. No patients showed signs of hypotension. The first urinalysis showed proteinuria,leukocyturia, and hematuria in 46%, 24%, and 23% of the patients, respectively. Overall, 40.7% of the patients showed some degree of renal involvement. • During hospitalization the peak serum creatinine level was 9.6 mg/dL(range: 0.4 - 9.6 mg/dL; mean: 1.31 mg/dL), and the prevalence of AKI was 34.5%. • Based on the pRIFLE classification stage I (risk group) was found in 20% of the patients, stageII (injury group) in 25% of the patients, and stage III (failure group) in 55% of the patients with AKI. • Compared to patients with normal renal function those with elevated serum creatinine levels on admission were predominantly older and more severely ill. • The total mortality rate of the patients was 12.67%. The rate of inhospital death among patients with AKI was estimated at 30%.
  • 26. • Independent predictors of AKI included; • being older • Black American • male • obesity • diabetes • hypertension • cardiovascular disease • low baseline estimated glomerular filtration rate (eGFR) • higher interleukin-6 level • requiring mechanical ventilation • vasopressor medications
  • 27. • Key points • • Over a quarter of patients hospitalized with coronavirus disease 2019 (COVID-19) • have been reported to develop acute kidney injury (AKI). • • Low molecular weight proteinuria, Fanconi syndrome and histological findings point • towards tubular injury. • • Analyses of kidney biopsy samples from patients with COVID-19 and AKI have • inconsistently reported viral infection of kidney cells. • • Collapsing glomerulopathy has been identified in patients with high- risk APOL1 • genotypes, mostly in those without severe respiratory symptoms. • • Regional inflammation, endothelial injury and renal microthrombi have been reported • • Anti- inflammatory drugs (for example, steroids and IL-6 receptor blockers) seem to • limit the development of severe AKI in patients with COVID-19.